“Baby John Box Office Day 8: Pushpa 2 and Mufasa Eclipse Varun Dhawan’s Film”
Baby John, the latest action-packed film starring Varun Dhawan, has been facing tough competition at the box office.
Baby John Box Office Day 8: Pushpa 2 and Mufasa Eclipse Varun Dhawan’s Film
Baby John, the latest action-packed film starring Varun Dhawan, has been facing tough competition at the box office. On its eighth day, the film’s collections have been overshadowed by the continued success of Pushpa 2 and the impressive performance of Mufasa. According to recent reports, Baby John has managed to collect around ₹12.50 crore on its first day, but its earnings have been declining steadily since then.
Pushpa 2, on the other hand, has been dominating the box office, with its third-week collections surpassing ₹19.75 crore on its 21st day. The film has already garnered over ₹1,109 crore nett in India, with the Hindi version contributing ₹716.65 crore nett. Mufasa, the animated feature from Disney, has also been performing well, collecting ₹14.25 crore nett on its sixth day and accumulating ₹67.85 crore nett in the Indian market.
Read more: Celebrating Vidya Balan: A Cinematic Icon’s Journey on Her Birthday
The competition from these two films has affected Baby John’s box office performance, with the film experiencing a notable decline in its collections on subsequent days. Despite featuring a strong cast, including Keerthy Suresh and Wamiqa Gabbi, Baby John has only managed to cross the ₹20 crore mark on its fourth day. The film’s overall performance has been modest, with a Hindi occupancy rate of 24.97% on its debut.
Varun Dhawan’s return to the main lead after two years has not been able to generate the expected buzz, with the film’s collections being outshone by Pushpa 2 and Mufasa. The film’s producers had invested an estimated budget of ₹180 crore, but the returns so far have been disappointing.
We’re now on WhatsApp. Click to join.
Like this post?
Register at One World News to never miss out on videos, celeb interviews, and best reads.